Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid-Reference-Cited by-同舟云学术

Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid

Published:2013-12 Issue:12 Volume:54 Page:3403-3418
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Navab Mohamad,Hough Greg,Buga Georgette M.,Su Feng,Wagner Alan C.,Meriwether David,Chattopadhyay Arnab,Gao Feng,Grijalva Victor,Danciger Janet S.,Van Lenten Brian J.,Org Elin,Lusis Aldons J.,Pan Calvin,Anantharamaiah G.M.,Farias-Eisner Robin,Smyth Susan S.,Reddy Srinivasa T.,Fogelman Alan M.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference42 articles.

1. Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis;Getz;J. Inflamm. Res.,2011

2. High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature;Navab;Arterioscler. Thromb. Vasc. Biol.,2012

3. Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients;Bloedon;J. Lipid Res.,2008

4. Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function;Watson;J. Lipid Res.,2011

5. Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally;Navab;J. Lipid Res.,2011

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multiple roles of lysophosphatidic acid in vascular disease and atherosclerosis;Current Opinion in Lipidology;2023-07-27

2. Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis;Journal of Lipid Research;2023-05

3. High density lipoprotein as a therapeutic target: Focus on its functionality;BIOCELL;2023

4. Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges;Critical Reviews™ in Therapeutic Drug Carrier Systems;2023

5. Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice;Arteriosclerosis, Thrombosis, and Vascular Biology;2022-08